Prelude Capital Management’s Safeguard Scientifics, Inc. SFE Stock Holding History

Prelude Capital Management’s Portfolio SFE Stock Details SFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-800	Closed	-$10K	–	1877
2016 Q2	$10K	Buy	+800	New	+$10.7K	﹤0.01%	1392
2016 Q1	–	Sell	-4,400	Closed	-$64K	–	1587
2015 Q4	$64K	Buy	4,400 +1,200	+38%	+$19.4K	0.01%	975
2015 Q3	$50K	Buy	+3,200	New	+$57.4K	0.01%	1065
2013 Q4	–	Sell	-400	Closed	-$6K	–	1980
2013 Q3	$6K	Buy	+400	New	+$6.16K	﹤0.01%	1430

Other funds holding SFE

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Prelude Capital Management's SFE Position: Q3 2016 in Review

Prelude Capital Management sold out of Safeguard Scientifics, Inc. (SFE) in Q3 2016, closing a stake of 800 shares — an estimated $10K sold.

Prelude Capital Management first reported a position in SFE in Q3 2013 and held it in 4 quarters. The position peaked at $64K in Q4 2015. 107 funds tracked by Wall St. Rank hold SFE as of Q3 2016.

Prelude Capital Management reported no remaining Safeguard Scientifics, Inc. position as of Q3 2016 after selling out during the quarter.
Prelude Capital Management sold 800 Safeguard Scientifics, Inc. shares in Q3 2016, an estimated $10K.
Prelude Capital Management first reported a position in Safeguard Scientifics, Inc. in Q3 2013 and held it in 4 quarters.
Prelude Capital Management's Safeguard Scientifics, Inc. position peaked at $64K in Q4 2015.
107 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q3 2016.

Based on Prelude Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.